Search Results

are a major contributor to cancer- and treatment-related morbidity and mortality. Exocrine pancreas cancer is one of the most common malignancies associated with thrombosis, with most modern studies reporting incidence ranging from 5% to 27%. 1 – 6

HA 3rd Moore MJ Anderson J . Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial . J Clin Oncol 1997 ; 15 : 2403 – 2413 . 3 Neoptolemos JP

gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial . J Clin Oncol 1997 ; 15 : 2403 – 2413 . 4. Allison DC Piantadosi S Hruban RH . DNA content and other factors associated with ten-year survival

pancreas cancer; (C) unresected pancreas cancer; and (D) non–small cell lung cancer. Table 3 Relationships Between Survival and Grade III/IV Treatment-Related Lymphopenia were controlled for, a relationship between TRL and survival was

Pancreas Cancer Olaparib Ongoing (POLO) trial reported the efficacy and safety of maintenance olaparib compared with placebo in patients with MPC with a germline BRCA mutation. 8 Results revealed that maintenance olaparib notably prolonged median

/7/13 Liver-Directed Therapies in Patients With Advanced Neuroendocrine Tumors Expiration Date: 6/4/13 Exocrine Pancreas Cancer and Thromboembolic Events: A Systematic Literature Review Expiration Date: 7/7/13 Monitoring Minimal Residual Disease in

/4/13 Exocrine Pancreas Cancer and Thromboembolic Events: A Systematic Literature Review Expiration Date: 7/7/13 Monitoring Minimal Residual Disease in Acute Myeloid Leukemia: Ready for Prime Time? Expiration Date: 8/7/13 Androgen Deprivation Therapy

CME/CE articles published in previous issues of JNCCN: Exocrine Pancreas Cancer and Thromboembolic Events: A Systematic Literature Review Expiration Date: 7/7/13 Monitoring Minimal Residual Disease in Acute Myeloid Leukemia: Ready

discussion of this is the subject of my article 4 and beyond the scope of this response. I would like, however, to illustrate this struggle by pointing out that in a randomized clinical trial of prophylaxis in patients with pancreas cancer, VTE during

Thaler HT . Pain and depression in patients with newly diagnosed pancreas cancer . J Clin Oncol 1995 ; 13 : 748 – 755 . 15. Passik SD Roth AJ . Anxiety symptoms and panic attacks preceding pancreatic cancer diagnosis . Psychooncology